Uflex Ltd (UFLEX) Q3FY25 Concall Summary - Dec-2024 Qtr
Performance Overview
- Uflex Ltd. reported a strong Dec-2024 quarter with a 12.8% year-on-year revenue growth, reaching INR 3,774 crores, driven by a 6.3% volume growth.
- EBITDA margin expanded significantly to 13.8% compared to 11.4% in the previous quarter, indicating improved profitability.
- Aseptic Packaging capacity utilization exceeded 100%, reaching 104%, showcasing robust demand and operational efficiency.
- Key overseas plants, including Nigeria and Mexico, witnessed substantial improvements in capacity utilization, reaching 90% and 98%, respectively.
- The company returned to profitability with a positive PAT of INR 111 crores, attributed to operational improvements and positive currency devaluation impact.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.